NasdaqGS:BIIBBiotechs
Biogen (NasdaqGS:BIIB) Partners With City Therapeutics in US$1 Billion RNAi Therapy Deal
Biogen (NasdaqGS:BIIB) recently announced a collaboration with City Therapeutics, Inc. to develop RNAi therapies for central nervous system diseases, contributing to a 6% share price increase over the past month. While this move aligns with an uptick in the broader tech sector due to policy shifts, other market responses could have influenced this rise. The announcement coincided with positive market momentum, as evident from major indexes inching upwards during this period, reflecting...